VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

HepaRegenix

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

HepaRegeniX develops a new and unique therapeutic concept to combat multiple liver diseases.

Also known as HepaRegeniX GmbH

  • Biotech & therapeutics
Headquarters
Tuebingen, Germany
Legal name
HepaRegeniX GmbH
Claim, correct or request removal

Record updated 23 September 2026

About

HepaRegeniX aims at curing liver diseases by reversing the disease path through liver regeneration. Along this path, the company is actively developing novel therapies for the treatment of both acute and chronic liver diseases.

Funding snapshot

Latest round
Undisclosed2025-04-15

Funding rounds

Round, 2025
2025-04-15
Series C
2024-07-10

Products

Web
HRX-215
Web
HRX-233
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy